
If your portfolio has Pharma stocks, then these news is very important for coming because there may be many big announcements. Us President Donald Trump is not taking the name of the Tariff. Trump applied 26% tariff rate on India but kept the Pharma Sector untouched but 8 April the Donald Trump itself announced the installation of tariffs on Pharmaceutical Companies and since which has been a tension in Pharma Companies. This tariff will affect both India and US countries. Indian pharma manufacturers earn from 30% to 50% from American Market. Let us talk about India’s 4 Indian Pharmaceutical Firms, whose stocks can be on high risk due to the tariff. So Dr Reddy’s Laboratories, Aurobindo Pharma, Zydus Lifescienes and Sun Pharma. Will it be right to buy these stocks during this Trade War, watch the video to know.